Viagra could be medics’ secret weapon against breast cancer, Israeli research finds
While the little blue pill is marketed as a gentleman’s bedroom aid, scientists as the Weizmann Institute found that it can also slow the rate at which aggressive cancers spread
Assessment
A study from the Weizmann Institute suggests that sildenafil, the active ingredient in Viagra, may slow the spread of aggressive breast cancers. This repurposing of an existing drug could offer a faster, cheaper path to new treatment options. The key question is whether clinical trials will confirm the effect in human patients.